Concepedia
Statistics
Publications
3
Citations
180
H-Index
Active since
2017
Affiliations
Cypralis (United Kingdom)(Current)
Gilead Sciences (United States)
Andrew J. Keats is an author at Cypralis (United Kingdom) specializing in pharmacology, drug design, and drug discovery.
Publications per year
2017–2021
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle
Richard L. Mackman, Victoria A. Steadman, David K. Dean et al. · Journal of Medicinal Chemistry · 2018 · 78 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A
Victoria A. Steadman, S. Pettit, Karine G. Poullennec et al. · Journal of Medicinal Chemistry · 2017 · 58 citations · Full text
Fast acting allosteric phosphofructokinase inhibitors block trypanosome glycolysis and cure acute African trypanosomiasis in mice
I.W. McNae, James Kinkead, Divya Malik et al. · Nature Communications · 2021 · 44 citations · Full text
Veterinary Medicine, Infectious Diseases, Pharmacology +17
1–3 of 3